ARLINGTON, Va. — The November midterm elections, which resulted in Republicans taking control of the Senate, also saw “significant Republican gains in state legislatures,” according to an analysis of the results by the National Association of Chain Drug Stores. Three state legislatures and four governorships swung to Republican control following the election. With victories in
Changes within the executive ranks in the chain drug industry are coming at a faster pace these days than at any time in the industry’s history. Most recently, Walgreens announced a new chief merchant, as a former Sam’s Club merchant, Linda Filler, was appointed to fill a position that was once held by Vern Brunner
Sweeping changes will begin to transform the pharmaceutical supply chain at the start of 2015, when the first provisions of the Drug Supply Chain Security Act take effect. The landmark legislation, which was enacted late last year, is intended to strengthen the integrity of the system that moves medications from drug manufacturers to distributors and
In a multipart series during 2014, our team is examining key product attributes and marketing tactics from two different perspectives — the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In this column, we explore the ways promotion impacts buyer and shopper behavior.
The passage of the Patient Protection and Affordable Care Act in 2010 (ACA) promised fundamental changes in the American health care environment. In turn, many in the chain pharmacy community were intrigued, if not excited, about the potential growth in prescription utilization and expansion of medication therapy management that the ACA promised to bring. Yet,
Can retail pharmacies beat other players to patient intimacy? Many pharmacy retailers understand that big data can improve business operations, enabling intimate consumer engagement and thereby driving bigger baskets and more door turns, along with healthier customers and margins. They see impacts almost completely confined to the income statement. Too few grasp the strategic ability
GREAT NECK, N.Y. — First Quality Tissue, a manufacturer of private-label and branded paper towels and tissue, is moving forward with several capacity expansion projects. Earlier this year, First Quality announced plans to deploy two additional TAD paper machines, and this week the company said it has selected its Lock Haven, Pa., facility as the
FORT WORTH, Texas — Galderma Laboratories’ Cetaphil skin care brand has made a foray in the baby product arena with the launch of Cetaphil Baby. Making its debut this week, the line includes five products: Cetaphil Baby Diaper Cream, Wash and Shampoo, Ultra Moisturizing Wash, Daily Lotion and Moisturizing Oil. Galderma said Cetaphil Baby is
ALISO VIEJO, Calif. — Avanir Pharmaceuticals Inc. has entered into an agreement to be acquired by Otsuka Pharmaceutical Co. Ltd. in a deal valued at $3.5 billion. Avanir said Tuesday that the acquisition ransaction, for $17 per share in cash, has been unanimously approved by the boards of directors of both companies and that Otsuka
DUBLIN, Ireland — Actavis plc has released guanfacine hydrochloride tablets as part of a settlement agreement with Shire plc. Actavis said Monday that its product is a generic version of Shire’s Intuniv tablets, a medication for attention deficit hyperactivity disorder (ADHD). Shipment of the generic product has commenced and, under Hatch-Waxman rules, it’s entitled to
JERUSALEM — Teva Pharmaceutical Industries Ltd. has launched amlodipine/valsartan/hydrochlorothiazide tablets, a hypertension medication, in the United States. Teva said Monday that its product is a generic equivalent of Exforge HCT tablets from Novartis. In addition, Teva reported that it was first-to-file, opening the generic market for the product and making it eligible for 180 days
PURCHASE, N.Y. — PepsiCo make has made a pair of key executive appointments for its global operations. The food and beverage giant said Monday that Enderson Guimaraes, currently chief executive officer of PepsiCo Europe, has been named executive vice president of global categories and operations for PepsiCo. He will be responsible for overseeing the company’s
FAIRFIELD, Calif. — Jelly Belly Candy Co. has introduced Draft Beer Jelly Bean Bottles in their own point-of-purchase display. Jelly Belly said Tuesday that the miniature plastic bottle is filled with 1.5 ounces of the Jelly Belly Draft Beer jelly beans, which made their debut this past spring. The Draft Beer Jelly Bean Bottles are
DUBLIN, Ireland — Endo International plc has purchased the rights to Natesto testosterone nasal gel from Trimel BioPharma SRL, a subsidiary of Trimel Pharmaceuticals Corp. Endo said Monday that Natesto, approved by the Food and Drug Administration in May of 2014, is the first and only testosterone nasal gel for replacement therapy in men diagnosed
